Activities of Mireille D'ORNANO related to 2017/2951(RSP)
Institutional motions (1)
MOTION FOR A RESOLUTION on vaccine hesitancy and the drop in vaccination rates in Europe PDF (280 KB) DOC (61 KB)
Oral questions (2)
Vaccine hesitancy and the drop in vaccination rates in Europe PDF (187 KB) DOC (18 KB)
Vaccine hesitancy and the drop in vaccination rates in Europe PDF (185 KB) DOC (18 KB)
Amendments (25)
Amendment 1 #
Citation 1 a (new)
- having regard to Article 6 of the Treaty on the Functioning of the European Union,
Amendment 4 #
Recital C
C. Wwhereas within the EU/EEA, countries vary considerably with respect to recommended vaccines and organisation of health services, given that protection and improvement of human health are matters for the Member States and cannot be subject to legally binding acts outside the national framework;
Amendment 5 #
Recital D a (new)
Da. whereas, in accordance with Article 6 of the Treaty on the Functioning of the European Union, the protection and improvement of human health are supporting competences, in respect of which the Commission is authorised to act only to support, coordinate or supplement the actions of the Member States, and whereas, therefore, legally binding acts of the European Union cannot require harmonisation of the laws and regulations of the European States,
Amendment 7 #
Recital E a (new)
Ea. whereas mass vaccination can eradicate a number of diseases and thus avoid epidemics which could cause many deaths;
Amendment 9 #
Recital F a (new)
Fa. whereas in some Member States public mistrust of vaccines is growing significantly, leading to a worrying refusal to vaccinate;
Amendment 16 #
Paragraph 2
2. Welcomes that the introduction of the large-scale protective vaccinations in Europe has significantly contributed to the eradication or decline in many infectious diseases; Nnevertheless, is concerned that the above achievements are now gravely challenged by the worrying phenomenon of vaccine hesitancy, which is based on a lack of information or exposure to false information;
Amendment 21 #
Paragraph 3
3. Points out that Vvaccines are safe according to the WHO and national health agencies, as a licensed vaccine is rigorously tested across multiple phases of trials before its use is approved, and regularly reassessed once it is on the market;
Amendment 27 #
Paragraph 4
4. WelcomesTakes note of the active engagement of the Commission on the issue of vaccination and the inclusion of a Joint Action Plan on vaccination, co- funded by the EU Health Programme, in the 2018 Commission Work Programme;
Amendment 33 #
Paragraph 5
5. Strongly supports the Joint Procurement Agreement, which gives Member States and the Commission a framework to jointly procure vaccines, thereby pooling the purchasing power of Member States, ensuring that pandemic vaccines are available in sufficient quantities and avoiding any risk of stocks running out, that access to vaccines is guaranteed, and that all participating Member States are treated equally;
Amendment 35 #
Paragraph 6
6. Welcomes the fact that 24 Member States have signed the Joint Procurement Agreement, meaning that the Agreement covers 447.8 million of the 508.2 million EU citizens; calls on those Member States which have not yet signed the Joint Procurement Agreement to do so to ensure that all EU citizens are covered by the agreement; calls on the Commission to look into the possibility of extending the pooling of purchasing power to all Member States of the European Economic Area and of the Council of Europe;
Amendment 37 #
Paragraph 7
7. Recalls the importance of transparency in building and maintaining public trust in medicines, including vaccines, given the growing phenomenon of vaccine hesitancy in several Member States;
Amendment 39 #
Paragraph 8
8. Recalls the importance of the Clinical Trials Regulation in stimulating and facilitating research into new vaccinations and ensuring transparency of results of clinical trials; calls on the Commission and the European Medicines Agency to implement the Clinical Trials Regulation without further delay and to promote publication of the results, in order to inform the public in the Member States and provide reassurance with respect to any concerns they may have;
Amendment 43 #
Paragraph 9
9. Calls on Member States to ensure that all healthcare workers are sufficiently vaccinated themselves; calls on the Commission to addresscoordinate the vaccination rates of healthcare workers in the Joint Action Plan;
Amendment 45 #
Paragraph 10
10. Notes with concern that epidemiological data on the current situation of vaccination in the Member States shows important gaps in the uptake of vaccines and insufficient vaccination coverage rates necessary to ensure adequate protection; is concerned that widespread vaccine hesitancy has become a worrying phenomenon due to the range of health-related consequences it causes in the Member States; is alarmed at the spread of false information on the internet, which is contributing to public hesitancy;
Amendment 52 #
Paragraph 11
11. Is concerned by the wide variation in the vaccines that are recommended, provided and/or mandated by different Member States and by the insufficient financial support for vaccination provided by the social security authorities in a number of Member States; is concerned that this variation in vaccination coverage exacerbates health inequalities between Member States and undermines efforts to reduce and eliminate preventable diseases;
Amendment 57 #
Paragraph 12
12. Condemns the spread of unreliable, misleading and unscientific information on vaccination aggravated by media controversies; calls on Member States and the Commission to take effective steps against the spread of such misinformation and to further develop awareness and information campaigns, especially for parents, including the creation of a European platform aimed at increasing vaccination coverage, while nevertheless upholding freedom of expression, as education must take precedence over censorship, the perverse effect of which is to consolidate unfounded beliefs;
Amendment 65 #
Paragraph 13
13. Is concerned about the high prices of someset by some pharmaceutical laboratories for life-saving vaccines; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines;
Amendment 67 #
Paragraph 14
14. Is concerned that high vaccine prices disproportionately affect low and middle income countries, including countries that are losing donor support through Gavi, the Vaccine Alliance; calls on the Commission and Member States to take measures to help facilitate access to vaccines in those countries; calls, therefore, on social security institutions to step up their demands in negotiations with pharmaceutical companies on the setting of vaccine prices;
Amendment 71 #
Paragraph 15
15. WelcomStresses the encouraging progress made inimportance of the fight against cervical cancer thanks to; draws attention, nevertheless, to the potential side-effects of vaccination programmes against the HPV virus; calls on the Member States to further develop these programmes and explore ways to increase coverage rates and prevent other forms of cancer, for example by including boys in vaccination programme transparency of these vaccination programmes and prevent other forms of cancer, including male cancers;
Amendment 74 #
Paragraph 16
16. Believes providing vaccination services for migrants and refugees entering EU countries is critical since mass vaccination can eradicate a number of diseases and thus avoid epidemics which could cause many deaths; calls on the Commission and Member States to map what concrete vaccination activities are being implemented for migrants and refugees entering EU countries and work to address the identified gaps;
Amendment 76 #
Paragraph 16
16. Believes providing vaccination services for migrants and refugees entering EU countries is critical; calls on the Commission and Member States to map what concrete vaccination activities are being implemented for migrants and refugees entering EU countries and work to address the identified gaps;
Amendment 80 #
Paragraph 17
17. Calls on the Member States and on the Commission to promote awareness- raising campaigns among physicians who provide vaccinations underlining their obligations, including providing patients (or patients’ legal guardians) with sufficient information about compulsory and recommended vaccines so that they can make an informed decision;
Amendment 86 #
Paragraph 18
18. Calls on the Commission and the Member States to elaborate a fully comprehensive EU Action Plan raising the social problem of vaccine hesitancy, strengthening Member States’ commitments, including priority and region-specific actions, and taking into account the varying circumstances and specific challenges faced by the Member States;
Amendment 89 #
Paragraph 19
19. Calls on the Commission to facilitcoordinate a more harmonised schedule for vaccination across the EU, to shareupplement best practice, between countries, to support Member States' action to ensure even coverage across Europe and reduce health inequalities;
Amendment 100 #
Paragraph 20
20. Calls on the Member States to punctually provide data on vaccination to the European Centre for Disease Prevention and Control;